van der Mey A G, Cornelisse C J, Hermans J, Terpstra J L, Schmidt P H, Fleuren G J
Department of Otolaryngology, University Hospital, Leiden, The Netherlands.
Br J Cancer. 1991 Feb;63(2):298-302. doi: 10.1038/bjc.1991.69.
Paragangliomas (glomus tumours) are benign, hypervascular tumours which in general are treated by surgical excision. The indication for treatment of these often slow-growing tumours needs additional criteria for predicting tumour progressiveness. For this reason the nuclear DNA content of 99 paragangliomas, 65 of them originating from patients with a positive family history, was analysed by flow cytometry. Unequivocal evidence of DNA aneuploidy was found in 37% of these clinically and histologically benign tumours, the average duration of follow up amounting to at least 10 years. The DNA index of the aneuploid tumours ranged from 0.90 to 2.03. No correlation was found between DNA ploidy and familiality or between DNA content and clinical criteria indicative of tumour progression, which means that DNA ploidy of these tumours cannot serve as a predictor for an expected growth pattern or familiality. DNA aneuploidy in hereditary and sporadic paragangliomas is not clinically related to malignancy, but indicates that these tumours are true neoplasias cytogenetically.
副神经节瘤(球瘤)是良性的、血管丰富的肿瘤,一般通过手术切除进行治疗。对于这些通常生长缓慢的肿瘤,其治疗指征需要额外的标准来预测肿瘤的进展情况。因此,采用流式细胞术分析了99例副神经节瘤的核DNA含量,其中65例来自有阳性家族史的患者。在这些临床和组织学上均为良性的肿瘤中,37%发现了明确的DNA非整倍体证据,平均随访时间至少为10年。非整倍体肿瘤的DNA指数范围为0.90至2.03。未发现DNA倍性与家族性之间或DNA含量与指示肿瘤进展的临床标准之间存在相关性,这意味着这些肿瘤的DNA倍性不能作为预期生长模式或家族性的预测指标。遗传性和散发性副神经节瘤中的DNA非整倍体在临床上与恶性肿瘤无关,但表明这些肿瘤在细胞遗传学上是真正的肿瘤。